의료기기 이야기

[한국체외진단의료기기협회] 2025년 체외진단의료기기 임상적 성능시험 종사자 교육 안내

한국체외진단의료기기협회가 임상적성능시험 종사자 교육기간으로 지정되어, 상시 온라인과정을 개설하였다. ▶ 교육명- 심사자(IRB), 모니터요원, 시험책임자 및 담당자 각 과정의 기본 / 전문(1)- 보수과정, 임상적 성능시험 통계기법 ▶ 교육기간2025년 03월 26일 ~ 12월 12일(금)까지 ▶ 교육목표임상적 성능시험기관 종사자 역량강화를 통한 체외진단의료기기의 안전성 확보 및 품질향상 ▶ 접수기간2025년 03월 26일 ~ 12월 12일(금) ▶ 모집인원제한없음 ▶ 교육비무료 (2025년) ▶ 교육대상체외진단의료기기 임상적 성능시험 종사자  2025년 체외진단의료기기 임상적 성능시험 종사자 상시 온라인 교육 안내(의무 교육) > 공지사항 | 한국체외진단의료기기협회 KIVDA 한국체외진단의료기기협회식품..

[Emergo, UL] Article 16(4) MDR & IVDR Certification: What Medical Device Manufacturers Need to Know

As Notified Bodies (NBs) in the European Union (EU) begin to roll out Article 16(4)  of the European Medical Devices Regulation 2017/745 (MDR) and the European In-vitro Diagnostic Medical Device Regulation 2017/746 (IVDR)  certification schemes, we at Emergo by UL share our insights on the requirements set out in Article 16 and their applicability to importers, distributors and other natural or ..

Importance of reviewing warning lettersBy reviewing relevant U.S. Food and Drug Administration (FDA) warning letters, manufacturers can better understand areas of frequent concern related to quality management systems (QMS) and regulatory affairs. This can allow companies to focus on areas of highest risk as they continually assess and improve their internal procedures and processes. It also hel..

1. Foreword This guidance, relating to the application of Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) addresses the classification of in vitro diagnostic medical devices (IVDs) and provides clarifications on the classification rules as set out under Annex VIII. This classification guidance also applies to diagnostic or information society services performed on EU patie..

Legislative background on shortagesOn March 2, 2022, amendments to the legislation in Canada, Medical Devices Regulations (SOR/98-282, Part 1, Sections 62.21 to 62.26) came into force. These provisions discuss the notification of shortages to the regulator Health Canada. If an explicit device is delineated on the “List of Medical Devices- Notification of Shortages” and the manufacturer or import..

The technical document Terminologies for Categorized Adverse Event Reporting (AER): Terms, Terminology and Codes has been updated by The International Medical Device Regulators Forum (IMDRF) Adverse Event Terminology working group (AET WG). The current update consists of 36 newly added terms, changes to 56 existing terms and the retirement of eight terms. Release notes that provide a high-level ..

The IVD expert panel has provided new scientific advice on SARS-CoV-2. The advice highlights that while the virus can still cause serious illness, it no longer poses a life-threatening risk with a significant mortality rate for the general European population.  This information may affect how SARS-CoV-2 tests are classified under Regulation (EU) 2017/746. Manufacturers are encouraged to assess h..

BackgroundThe Chief Executive, Dr. Muralitharan Paramasua, of the regulator in Malaysia, the Medical Device Authority (MDA), hosted the 2025 keynote address (January 14).Many programs were presented: e-labeling, UDI, import permit, guidance documents, Medcast 3.0, additional recognized ASEAN countries, and Class A fees. This update focuses on one of the global harmonization/regulatory reliance i..

The Medicines and Healthcare products Regulatory Agency (MHRA) announced the release of a suite of post-market surveillance (PMS) guidance (January 15) in alignment with The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024. BackgroundAs Emergo by UL reported last month, the amendment introduces new and enhanced PMS requirements for manufacturer..

Manufacturers applying to register a medical device or IVD with the Australian Register of Therapeutic Goods (ARTG) now have more options to leverage to fulfill the Manufacturer Evidence requirement to support an application. As a result, manufacturers may leverage their EU CE Marking Certificate issued under the IVDD to fulfill the Manufacturer Evidence requirement until the dates listed below...